ENTPD3-AS1: A Protein Targeted for Neurodegenerative and Cancer Treatments

Target Name: ENTPD3-AS1

NCBI ID: G285266

ENTPD3-AS1

Other Name(s): RP11-391M1.3 | ENTPD3 antisense RNA 1

ENTPD3-AS1: A Protein Targeted for Neurodegenerative and Cancer Treatments

ENTPD3-AS1 (RP11-391M1.3), also known as ENT-PD3, is a protein that is expressed in the endoplasmic reticulum (ER) and is involved in the regulation of endoplasmic reticulum-to-cytosol transport (ER-to-Cyt) traffic. ENTPD3-AS1 plays a crucial role in the ER-to-Cyt transport of various cellular proteins, including membrane proteins, cytoskeletal proteins, and intracellular signaling molecules.

Recent studies have identified ENTPD3-AS1 as a potential drug target or biomarker for various diseases, including neurodegenerative disorders, cancer, and autoimmune diseases. The exact mechanism of action of ENTPD3-AS1 is not yet fully understood, but it is known to be involved in the regulation of protein transport from the ER to the cytosol, which is a critical step in the regulation of protein function and cell signaling.

One of the key challenges in studying ENTPD3-AS1 is its expression and function, as the ER-to-Cyt transport system is complex and highly regulated. To study its function, researchers have used a variety of techniques, including RNA sequencing, immunofluorescence, and biochemical assays. These studies have provided valuable insights into the regulation of ER-to-Cyt transport by ENTPD3-AS1 and its potential as a drug target.

In addition to its potential as a drug target, ENTPD3-AS1 has also been identified as a biomarker for various diseases. For example, ENTPD3-AS1 has been shown to be overexpressed in the brains of patients with Alzheimer's disease, a neurodegenerative disorder that is characterized by the progressive loss of brain cells. Additionally, ENTPD3-AS1 has been shown to be overexpressed in the blood vessels of patients with cancer, a disease that is characterized by the formation of tumors and the growth of cancer cells.

The potential utility of ENTPD3-AS1 as a drug target or biomarker makes it an attractive target for researchers to study and develop new treatments for a variety of diseases. While further research is needed to fully understand its mechanism of action and its potential as a drug, ENTPD3-AS1 is a promising molecule that could one day be used to treat a wide range of diseases.

Protein Name: ENTPD3 Antisense RNA 1

The "ENTPD3-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ENTPD3-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets